Literature DB >> 15327389

Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein.

Anthony J Bleyer1, Thomas C Hart, Zak Shihabi, Vicki Robins, John R Hoyer.   

Abstract

BACKGROUND: Mutations in the uromodulin (UMOD) gene that encodes Tamm-Horsfall protein (THP) cause an autosomal-dominant form of chronic renal failure. We have now investigated effects of UMOD gene mutations on protein expression by quantitatively measuring THP excretion.
METHODS: THP excretion was determined by enzyme-linked immunosorbent assay (ELISA) of urine collections obtained from 16 related individuals with a 27 bp deletion in the UMOD gene and seven individuals with other UMOD mutations. THP excretion of 22 control subjects (18 genetically related individuals and four spouses in the UMOD deletion family) was also determined.
RESULTS: The 16 individuals carrying the deletion mutation excreted 5.8 +/- 6.3 mg THP/g creatinine into their urine. The 18 unaffected relatives from the same family excreted 40.8 +/- 9.7 mg THP/g creatinine (P < 0.0001) and the four spouses excreted 43.9 +/- 25.1 mg THP/g creatinine (P < 0.0001 vs. individuals with the deletion mutation). THP excretion of seven individuals with other UMOD gene mutations was also extremely low (range of 0.14 to 5.9 mg THP/g creatinine). All individuals with UMOD mutations had low THP excretion, irrespective of gender, glomerular filtration rate (GFR), or age.
CONCLUSION: These studies quantitatively show that the autosomal-dominant gene mutations responsible for UMOD-associated kidney disease cause a profound reduction of THP excretion. We speculate that this suppression of normal THP excretion reflects deleterious effects of mutated THP within the kidney. Such effects may also play an important role in the pathogenesis of the progressive renal failure observed in patients with UMOD gene mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327389     DOI: 10.1111/j.1523-1755.2004.00845.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

Review 1.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

Review 2.  Biomarkers for incident CKD: a new framework for interpreting the literature.

Authors:  Michael G Shlipak; Erica C Day
Journal:  Nat Rev Nephrol       Date:  2013-06-11       Impact factor: 28.314

3.  Molecular and cellular effects of Tamm-Horsfall protein mutations and their rescue by chemical chaperones.

Authors:  Lijie Ma; Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 4.  From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.

Authors:  Gopalakrishnan Venkat-Raman; Christine Gast; Anthony Marinaki; Lynnette Fairbanks
Journal:  Pediatr Nephrol       Date:  2016-02-12       Impact factor: 3.714

Review 5.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

Review 6.  Hereditary interstitial kidney disease.

Authors:  Anthony J Bleyer; P Suzanne Hart; Stanislav Kmoch
Journal:  Semin Nephrol       Date:  2010-07       Impact factor: 5.299

7.  Tamm-Horsfall protein translocates to the basolateral domain of thick ascending limbs, interstitium, and circulation during recovery from acute kidney injury.

Authors:  Tarek M El-Achkar; Ruth McCracken; Yan Liu; Monique R Heitmeier; Soline Bourgeois; Jan Ryerse; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

8.  Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy.

Authors:  Matthew L Weaver; S Roger Qiu; John R Hoyer; William H Casey; George H Nancollas; James J De Yoreo
Journal:  Calcif Tissue Int       Date:  2009-03-18       Impact factor: 4.333

9.  Uromodulin levels associate with a common UMOD variant and risk for incident CKD.

Authors:  Anna Köttgen; Shih-Jen Hwang; Martin G Larson; Jennifer E Van Eyk; Qin Fu; Emelia J Benjamin; Abbas Dehghan; Nicole L Glazer; W H Linda Kao; Tamara B Harris; Vilmundur Gudnason; Michael G Shlipak; Qiong Yang; Josef Coresh; Daniel Levy; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

10.  Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy.

Authors:  P Vylet'al; H Hůlková; M Zivná; L Berná; P Novák; M Elleder; S Kmoch
Journal:  J Inherit Metab Dis       Date:  2008-07-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.